DOMS Industries Limited has successfully completed the acquisition of an additional 6.5% stake in its subsidiary Pioneer Stationery Private Limited, strengthening its control over the subsidiary company. The transaction was completed on March 31, 2026, as part of a larger strategic acquisition plan.

Transaction Details

The acquisition involved the purchase of 3,900 equity shares from certain existing shareholders of Pioneer Stationery Private Limited. The company disclosed the transaction details in its regulatory filing to the stock exchanges.

Shareholding Enhancement

Following this acquisition, DOMS Industries' shareholding in Pioneer has increased significantly. The transaction represents the completion of the remaining portion of a Board-approved acquisition plan.

Strategic Context

This acquisition is part of a larger Board-approved plan to acquire a total 13.0% stake in Pioneer Stationery Private Limited. The company had previously communicated about this acquisition plan in its letter dated December 29, 2025, indicating a phased approach to increasing its shareholding in the subsidiary.

Regulatory Compliance

The transaction was disclosed under Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. The company has informed both BSE Limited and National Stock Exchange of India Limited about the completion of this acquisition, ensuring full regulatory compliance and transparency with stakeholders.

DOMS Industries Limited has informed stock exchanges about a GST order received by its subsidiary Uniclan Healthcare Private Limited from tax authorities. The disclosure was made under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

GST Order Details

The Office of Superintendent of Central Taxes (CGST), Thane, issued the order under Section 74 and 122 of the CGST Act and relevant sections of MGST Act, 2017. The order was received by the company on March 20, 2026, and relates to financial year 2021-22.

Financial Impact and Allegations

The GST order addresses alleged wrongful availment of Input Tax Credit (ITC) and utilization of such ITC without actual receipt of the underlying goods or services. The financial implications include multiple components as detailed by the tax authorities.

Company Response and Impact Assessment

DOMS Industries has indicated that Uniclan Healthcare is evaluating appropriate legal remedies against the order and plans to file a response within the prescribed time limit. The company has assessed the potential impact on its operations and provided guidance on the matter.

The company has stated that there is no material impact on the financial, operations, or other activities due to this order. This assessment suggests that the subsidiary's legal challenges are not expected to significantly affect the parent company's overall business performance.

Regulatory Compliance

The disclosure was made in compliance with SEBI regulations, specifically referencing the company's earlier communication dated October 03, 2025. This demonstrates the company's adherence to transparency requirements for listed entities regarding material developments affecting subsidiaries.

The matter represents part of ongoing GST compliance challenges that companies face in the evolving tax landscape, with authorities scrutinizing Input Tax Credit claims and their proper utilization.